Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300459	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	License Renew	2023-12-21					view
JYHZ2300458	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	License Renew	2023-12-21					view
JYHB2300402	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2023-07-18					view
JYHB2300401	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2023-07-18					view
JYHB2100231	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2021-03-31	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	In Review	2021-03-30	view
JYHB2100230	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2021-03-31	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	In Review	2021-03-30	view
JYHB2001278	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-08-06	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-08-19	view
JYHB2001161	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-07-04	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-12-10	view
JYHB2001160	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-07-04	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-12-10	view
JYHB2000732	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-06-06	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-16	view
JYHB2000582	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-05-13	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-05-25	view
JYHB2000084	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-01-22	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-02-17	view
JYHB1901224	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2019-10-23	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-01-03	view
JYHB1800264	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-01	view
JYHB1800263	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-08	view
JXHS2300006	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2023-01-07					view
JXHS2300005	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2023-01-07					view
JXHS2200004	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2022-01-10					view
JXHS2200003	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2022-01-10					view
JXHS1800010	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs(5.1)	Import Drug Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-08	view